Abiopharma

New Form 8-K - Sana Biotechnology, Inc. Filed: 2025-09-05 AccNo: 0001193125-25-196414 Size: 168 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 8.01: Other Events

New Form EFFECT - PURPLE BIOTECH LTD. Filed: 2025-09-04 AccNo: 9999999995-25-002842 Size: 1 KB

New Form EFFECT - iTeos Therapeutics, Inc. Filed: 2025-09-04 AccNo: 9999999995-25-002827 Size: 1 KB

New Form EFFECT - AETHLON MEDICAL INC Filed: 2025-09-04 AccNo: 9999999995-25-002837 Size: 1 KB

New Form EFFECT - Tharimmune, Inc. Filed: 2025-09-04 AccNo: 9999999995-25-002839 Size: 1 KB

New Form EFFECT - Tonix Pharmaceuticals Holding Corp. Filed: 2025-09-04 AccNo: 9999999995-25-002831 Size: 1 KB

Biodesix to Participate in Lake Street CapitalMarkets’ 9th Annual Best Ideas Growth (BIG9) Conference

Change - Change of Catalist Sponsor: CHANGE OF CONTINUING SPONSOR

BioNTech and DualityBio Announce Phase 3 Trial of ADC Candidate BNT323/DB-1303 Met Primary Endpoint of Progression Free Survival in HER2-Positive Metastatic or Unresectable Breast Cancer

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

FDA approve FLUOCINOLONE ACETONIDE

FDA approve DORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATE

FDA approve ZIPRASIDONE MESYLATE

FDA approve SELEGILINE HYDROCHLORIDE

FDA approve FLUOCINOLONE ACETONIDE